Michael J Coleman
CIK 1039011 · Auf SEC EDGAR ansehen ↗
Insider
Erste SEC-Einreichung: 1. Oktober 2010 · Neueste: 1. Oktober 2010
Auf dieser Seite
Insider bei
Insider-Transaktionen
0 Käufe (P)
0 Verkäufe (S)
Netto:
$0
+ 93 nicht börsennotierte Transaktionen unten
letzte 12 Monate, basierend auf den unten gezeigten Transaktionen
Preisänderung im Vergleich zum aktuellen Kurs, bereinigt um Aktiensplits und Unternehmensmaßnahmen seit der Einreichung – nicht benchmarkt, nicht annualisiert, nicht größen-gewichtet
93 weitere Einreichungen ausgeblendet
| Date | Ticker | Code | Aktien | Kurs | Wert | Besessen danach | Δ Eigenbesitz | A/D | vs jetzt |
|---|---|---|---|---|---|---|---|---|---|
| 10. Mai 2019 | XRAY | S | 9.160 | $54,90 | $502.884 | 22.223 Direkt | -29,19% | Veräußert | -80,1% (Preis per 2026-08-20) |
| 1. Juni 2018 | XRAY | S | 1.196 | $43,98 | $52.600 | 22.118 Direkt | -5,13% | Veräußert | -75,1% (Preis per 2026-08-20) |
| 1. Juni 2018 | XRAY | S | 4.842 | $43,97 | $212.903 | 22.118 Direkt | -17,96% | Veräußert | -75,1% (Preis per 2026-08-20) |
| 10. Mai 2018 | XRAY | S | 414 | $46,66 | $19.317 | 20.236 Direkt | -2,00% | Veräußert | -76,6% (Preis per 2026-08-20) |
| 21. Februar 2017 | XRAY | S | 481 | $62,73 | $30.173 | 8.312 Direkt | -5,47% | Veräußert | -82,6% (Preis per 2026-08-20) |
| 20. Februar 2015 | XRAY | S | 18.000 | $52,47 | $944.460 | 6.879 Direkt | -72,35% | Veräußert | -79,1% (Preis per 2026-08-20) |
| 3. Mai 2012 | XRAY | S | 18.000 | $40,19 | $723.420 | 6.877 Direkt | -72,36% | Veräußert | -72,8% (Preis per 2026-08-20) |
Zeige die neuesten 100 von 183 Transaktionen
K = Kauf auf offener Markt · V = Verkauf · A = Zuteilung/Auszeichnung · M = Optionsausübung · G = Geschenk · F = Steuereinbehalt
Insider-Transaktionen sind keine Empfehlung; Verkäufe werden oft aus Liquiditäts- oder steuerlichen Gründen getätigt.
Derivate-Bestände (Formular 4 Tabelle II)
Optionen, RSUs und wandelbare Wertpapiere, die in Formular 4 Tabelle II gemeldet werden.
| Date | Ticker | Wertpapier | Basiswert | Ausübungspreis | Verfall | Aktien | A/D |
|---|---|---|---|---|---|---|---|
| 10. Mai 2019 | XRAY | Stock Option (Right to Buy) | Common Stock (9.160) | $29,70 | 12. Mai 2019 | 9.160 | Veräußert |
| 12. April 2019 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (33) | — | — | 33 | Erworben |
| 11. Januar 2019 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (42) | — | — | 42 | Erworben |
| 12. Oktober 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (26) | — | — | 26 | Erworben |
| 13. Juli 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (37) | — | — | 37 | Erworben |
| 1. Juni 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (1.196) | $39,39 | 28. Juli 2018 | 1.196 | Veräußert |
| 1. Juni 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (4.842) | $37,69 | 11. Juni 2018 | 4.842 | Veräußert |
| 23. Mai 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (8.500) | $46,50 | 23. Mai 2028 | 8.500 | Erworben |
| 10. Mai 2018 | XRAY | Stock Option (Right to Buy) | Common Stock (414) | $41,07 | 13. Mai 2018 | 414 | Veräußert |
| 13. April 2018 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (34) | — | — | 34 | Erworben |
| 12. Januar 2018 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Erworben |
| 29. Dezember 2017 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (25) | — | — | 25 | Erworben |
| 13. Oktober 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Erworben |
| 29. September 2017 | XRAY | Phantom Stock (Directors' Deferred Compensation) | Common Stock (28) | — | — | 28 | Erworben |
| 14. Juli 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Erworben |
| 30. Juni 2017 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Erworben |
| 24. Mai 2017 | XRAY | Stock Option (Right to Buy) | Common Stock (7.300) | $62,73 | 24. Mai 2027 | 7.300 | Erworben |
| 14. April 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Erworben |
| 31. März 2017 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Erworben |
| 21. Februar 2017 | XRAY | Stock Option | Common Stock (481) | $36,49 | 31. Juli 2017 | 481 | Veräußert |
| 13. Januar 2017 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Erworben |
| 30. Dezember 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Erworben |
| 14. Oktober 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Erworben |
| 4. Oktober 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Erworben |
| 8. Juli 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Erworben |
| 5. Juli 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Erworben |
| 25. Mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.214) | — | 25. Mai 2017 | 1.214 | Erworben |
| 25. Mai 2016 | XRAY | Stock Option (Right to Buy) | Common Stock (5.800) | $61,77 | 25. Mai 2026 | 5.800 | Erworben |
| 21. Mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.433) | — | 21. Mai 2016 | 1.433 | Veräußert |
| 21. Mai 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.431) | — | 21. Mai 2016 | 1.431 | Veräußert |
| 8. April 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (14) | — | — | 14 | Erworben |
| 22. März 2016 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Erworben |
| 8. Januar 2016 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Erworben |
| 15. Dezember 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Erworben |
| 9. Oktober 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Erworben |
| 22. September 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Erworben |
| 10. Juli 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (15) | — | — | 15 | Erworben |
| 23. Juni 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Erworben |
| 21. Mai 2015 | XRAY | Stock Option | Common Stock (6.700) | $52,61 | 21. Mai 2025 | 6.700 | Erworben |
| 21. Mai 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.426) | — | — | 1.426 | Erworben |
| 10. April 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Erworben |
| 24. März 2015 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (24) | — | — | 24 | Erworben |
| 20. Februar 2015 | XRAY | Stock Option | Common Stock (18.000) | $28,00 | 11. Juni 2015 | 18.000 | Veräußert |
| 9. Januar 2015 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 23. Dezember 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (23) | — | — | 23 | Erworben |
| 10. Oktober 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Erworben |
| 23. September 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Erworben |
| 11. Juli 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (13) | — | — | 13 | Erworben |
| 24. Juni 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Erworben |
| 21. Mai 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.390) | — | — | 1.390 | Erworben |
| 21. Mai 2014 | XRAY | Stock Option | Common Stock (6.500) | $46,77 | 21. Mai 2024 | 6.500 | Erworben |
| 11. April 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 24. März 2014 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Erworben |
| 10. Januar 2014 | XRAY | RSU (Restricted Stock Unit) | Common Stock (10) | — | — | 10 | Erworben |
| 26. Dezember 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (24) | — | — | 24 | Erworben |
| 11. Oktober 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (11) | — | — | 11 | Erworben |
| 24. September 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Erworben |
| 12. Juli 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (12) | — | — | 12 | Erworben |
| 25. Juni 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (29) | — | — | 29 | Erworben |
| 22. Mai 2013 | XRAY | Stock Option | Common Stock (6.200) | $41,47 | 22. Mai 2023 | 6.200 | Erworben |
| 22. Mai 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.567) | — | — | 1.567 | Erworben |
| 12. April 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (9) | $0,00 | — | 9 | Erworben |
| 22. März 2013 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (24) | — | — | 24 | Erworben |
| 11. Januar 2013 | XRAY | RSU (Restricted Stock Unit) | Common Stock (9) | — | — | 9 | Erworben |
| 20. Dezember 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Erworben |
| 24. September 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (27) | — | — | 27 | Erworben |
| 13. Juli 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $37,81 | — | 7 | Erworben |
| 25. Juni 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (28) | — | — | 28 | Erworben |
| 23. Mai 2012 | XRAY | Stock Option | Common Stock (6.900) | $38,02 | 23. Mai 2022 | 6.900 | Erworben |
| 23. Mai 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (1.710) | $0,00 | — | 1.710 | Erworben |
| 3. Mai 2012 | XRAY | Stock Option | Common Stock (18.000) | $18,63 | 11. Juni 2012 | 18.000 | Veräußert |
| 13. April 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | $40,13 | — | 6 | Erworben |
| 23. März 2012 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (26) | — | — | 26 | Erworben |
| 10. Januar 2012 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $34,99 | — | 7 | Erworben |
| 6. Oktober 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (7) | $32,43 | — | 7 | Erworben |
| 8. Juli 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (6) | $38,08 | — | 6 | Erworben |
| 8. Juli 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (54) | $38,08 | — | 54 | Erworben |
| 27. Juni 2011 | XRAY | Phantom Stock (Directors' Deferred Comp) | Common Stock (25) | — | — | 25 | Erworben |
| 25. Mai 2011 | XRAY | RSU (Restricted Stock Unit) | Common Stock (894) | $0,00 | — | 894 | Erworben |
| 25. Mai 2011 | XRAY | Stock Option | Common Stock (7.600) | $38,57 | 25. Mai 2021 | 7.600 | Erworben |
| 8. April 2011 | XRAY | RSU (Restricted Stock Unit) Granted | Common Stock (5) | $36,49 | — | 5 | Erworben |
| 25. März 2011 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (25) | $36,14 | — | 25 | Erworben |
| 7. Januar 2011 | XRAY | RSU (Restricted Stock Unit) Granted [F1] | Common Stock (5) | $34,54 | — | 5 | Erworben |
| 27. Dezember 2010 | XRAY | Directors' Deferred Comp (DDC) | Common Stock (26) | $34,54 | — | 26 | Erworben |
| 7. Oktober 2010 | XRAY | RSU (Restricted Stock Unit) Granted [F1] | Common Stock (5) | $31,87 | — | 5 | Erworben |
| 29. September 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (29) | — | — | 29 | Erworben |
| 30. Juli 2010 | XRAY | RSU (Restricted Stock Unit) | Common Stock (876) | — | 31. Juli 2017 | 876 | Veräußert |
| 8. Juli 2010 | XRAY | Additional RSUs [F1] | Common Stock (7) | $31,03 | — | 7 | Erworben |
| 28. Juni 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (29) | — | — | 29 | Erworben |
| 6. April 2010 | XRAY | Additional RSUs [F1] | Common Stock (5) | $34,17 | — | 5 | Erworben |
| 24. März 2010 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (26) | — | — | 27 | Erworben |
| 9. Januar 2010 | XRAY | Additional RSUs [F1] | Common Stock (4) | $35,44 | — | 4 | Erworben |
| 18. Dezember 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (26) | — | — | 26 | Erworben |
| 6. Oktober 2009 | XRAY | Phantom Stock (Deferred Compensation) | Common Stock (26) | $34,64 | — | 26 | Erworben |
| 6. Oktober 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $33,60 | — | 5 | Erworben |
| 7. Juli 2009 | XRAY | Additional RSUs [F1] | Common Stock (5) | $30,93 | — | 5 | Erworben |
| 22. Juni 2009 | XRAY | Phantom Stock-Director's Deferred Compensation | Common Stock (31) | $29,27 | — | 31 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.053) | $29,70 | 12. Mai 2019 | 3.053 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.054) | $29,70 | 12. Mai 2019 | 3.054 | Erworben |
| 12. Mai 2009 | XRAY | Stock Option | Common Stock (3.053) | $29,70 | 12. Mai 2019 | 3.053 | Erworben |
Zeige die neuesten 100 von 152 Transaktionen
Ausübungs-/Umwandlungspreis ist leer, wenn nicht zutreffend (z. B. RSUs).